September 14, 2018 — "CVS has limited this threshold to very few cases so [it] will likely not have a big impact," notes CP3 Director Walid Gellad in a Biopharma Dive article about CVS' use of ICER metrics for drug pricing. The company decided in August to use value-based drug pricing analyses to determine Read More »